Efficacy of a unique omega-3 formulation on the correction of nutritional deficiency and its effects on cardiovascular disease risk factors in a randomized controlled VASCAZEN® REVEAL Trial

Overview of attention for article published in Molecular and Cellular Biochemistry, September 2014

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#49 of 2,296)
High Attention Score compared to outputs of the same age (89th percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

news: 1 news outlet
twitter: 1 X user

patent: 1 patent

Citations

dimensions_citation: 15 Dimensions

Readers on

mendeley: 93 Mendeley

Summary News X Patents Dimensions citations

So far, Altmetric has seen 2 news stories from 1 outlets.

COMUNICADO: Pivotal recibe la notificación de patente de VASCAZEN® y el inhibidor de absorción de colesterol

Lainformacion.com , 09 Oct 2014

WOODBRIDGE, Ontario, October 9, 2014 /PRNewswire/ -- -- Pivotal recibe la notificación de permiso de patente de Estados Unidos…

COMUNICADO: Pivotal anuncia un ensayo que muestra los efectos beneficiosos de VASCAZEN® para corregir la deficiencia de Omega-3

Lainformacion.com , 15 Sep 2014

WOODBRIDGE, Ontario, September 15, 2014 /PRNewswire/ -- -- Pivotal anuncia la publicación de un ensayo clínico que muestra los…